Webinar: Calprotectin in infections

11. May 2022 | 2 min read

Webinar: Calprotectin in infections

Webinar: Calprotectin in infections

The webinar “Calprotectin in infections” looks into calprotectin’s role in infections. The webinar takes you through a quick introduction to the protein and biomarker calprotectin, followed by a summary of studies highlighting calprotectin in diagnosis and prognostics, as well as calprotectin in localised infections:

  • The biomarker calprotectin
  • Calprotectin as diagnostic marker in infections
  • Calprotectin as prognostic and risk marker
  • Calprotectin in localised infections

Watch the webinar now

 

 

GCAL® - Plasma and serum calprotectin immunoassay

The Gentian Calprotectin Immunoassay (GCAL®) is the first turbidimetric assay for the quantitative measurement of calprotectin in plasma and serum intended as an aid in the detection and assessment of inflammation. The open channel assay can be applied on a wide range of automated clinical chemistry analysers.

  • CE-marked and IVDR certified
  • Developed and manufactured by Gentian
  • Manufactured according to ISO 13485:2016


blood calprotectin

 

Get in touch for information and ordering

Interested in calprotectin for plasma and serum? Want to know more? Please send an email to marketing@gentian.com or fill out the form below:

 

 

New call-to-action

 




 

You may also read


Cystatin C, GFR and Shrunken Pore Syndrome: Insights from Dr. A. Grubb

Jan 20, 2026

Cystatin C, GFR and Shrunken Pore Syndrome: Insights from Dr. A. Grubb

Expanding the understanding of kidney disease Shrunken Pore Syndrome (SPS) and Selective Glomerular..

GCAL® Calprotectin - From insights to impact - January 2026

Jan 13, 2026

GCAL® Calprotectin - From insights to impact - January 2026

Continuing the GCAL® journey: Building on 2025, moving into 2026 Over the past year, interest in circulating..

Meet Gentian Diagnostics in 2026 - Conferences & Exhibitions

Jan 07, 2026

Meet Gentian Diagnostics in 2026 - Conferences & Exhibitions

Meet us at conferences in 2026 We will be attending a range of conferences and exhibitions throughout 2026...